Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Medicinas Complementárias
Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Bioelectromagnetics ; 19(3): 152-61, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9554693

RESUMEN

Vicia faba seedlings were subjected to one of the following magnetic fields continuously for 3 days: 0 Hz (DC) at 5 mT, 50 Hz at 1.5 mT, 60 Hz at 1.5 mT, and 75 Hz at 1.5 mT. The lengths of all the phases of mitosis differed from the controls in all treatments using alternating magnetic fields and for prophase and metaphase in the DC condition. In particular, all treatments increased the length of prophase significantly in meristematic root-tip cells compared with the controls. The implications of these results for chromosome coiling are discussed. The length of prophase, however, did not vary significantly between any of the treatments. Furthermore, none of the exposed seedlings had a greater frequency of chromosome breakages above that of the control plants.


Asunto(s)
Magnetismo/efectos adversos , Ciclo Celular , Aberraciones Cromosómicas , Cromosomas/ultraestructura , Fabaceae/citología , Fabaceae/genética , Mitosis , Plantas Medicinales , Factores de Tiempo
2.
Health Phys ; 48(5): 635-47, 1985 May.
Artículo en Inglés | MEDLINE | ID: mdl-3921492

RESUMEN

From extensive human data on the induction of skeletal cancers (bone sarcomas and carcinomas of the head sinuses) by 226Ra, 228Ra and 224Ra, the cumulative lifetime risk to 1 million people, each ingesting 5 pCi of a Ra isotope per day, was calculated to be nine bone sarcomas plus 12 head carcinomas for 226Ra, 22 bone sarcomas for 228Ra, and 1.6 bone sarcomas for 224Ra. Assuming that the risk per rad of average skeletal dose is equal for 226Ra and the U isotopes with half-lives exceeding 1000 yr and that the equilibrium skeletal content is 25 times the daily ingestion of 226Ra, but 11 times the daily ingestion of long-lived U, the cumulative life-span risk to 1 million persons, each ingesting 5 pCi per day of 233U, 234U, 235U, 236U or 238U, is estimated to be about 1.5 bone sarcomas. The U risk is not well established and additional research is needed on the metabolism of U in humans and its carcinogenicity in laboratory animals. These estimates assume linear dose responses. However, if incidence varies with the square of dose, virtually no induced cancers would be expected from these levels of radioactivity.


Asunto(s)
Neoplasias Inducidas por Radiación/epidemiología , Radio (Elemento)/efectos adversos , Uranio/efectos adversos , Partículas alfa , Neoplasias Óseas/etiología , Análisis Costo-Beneficio , Relación Dosis-Respuesta en la Radiación , Semivida , Neoplasias de Cabeza y Cuello/etiología , Humanos , Leucemia Inducida por Radiación/epidemiología , Esperanza de Vida , Matemática , Neoplasias Inducidas por Radiación/economía , Neoplasias Inducidas por Radiación/prevención & control , Enfermedades Profesionales/etiología , Dosis de Radiación , Riesgo , Sarcoma/etiología , Neoplasias de los Tejidos Blandos/etiología , Contaminantes Radiactivos del Agua/efectos adversos , Abastecimiento de Agua
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA